Variant report

Variant	nsv900800
Chromosome Location	chr13:88942502-89079092
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:0)
CpG islands
(count:0)
Chromatin interactive
region (count:2)
LncRNA
region (count:11)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

No data

(count:2 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type	Cell Stage
1	chr13:88973778..88975590-chr13:88975862..88978691,2	MCF-7	breast:
2	chr13:88973778..88975590-chr13:88975862..88978691,2	MCF-7	breast:

(count:11 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-SLITRK5-18	chr13:89001824-89001971	l_896_chr13:89001067-89003744_testes
2	lnc-SLITRK5-7	chr13:89063141-89063163	NONHSAT034614
3	lnc-SLITRK6-20	chr13:88998946-88999466	NONHSAT034612
4	lnc-SLITRK6-20	chr13:89001456-89001545	NONHSAT034612
5	lnc-SLITRK6-20	chr13:89003986-89004059	NONHSAT034612
6	lnc-SLITRK6-19	chr13:88950629-88950764	NONHSAT034611
7	lnc-SLITRK5-7	chr13:89063052-89063116	NONHSAT034614
8	lnc-SLITRK5-18	chr13:89001068-89001533	l_896_chr13:89001067-89003744_testes
9	lnc-SLITRK6-20	chr13:89001488-89001532	NONHSAT034613
10	lnc-SLITRK5-18	chr13:89002360-89003744	l_896_chr13:89001067-89003744_testes
11	lnc-SLITRK6-20	chr13:89002360-89002644	NONHSAT034613

No data

Extended variants
information (count: 905 )
Associated
traits (count: 86 )

Variant overlapped rSNPs/rCNVs (count:905 , 50 per page) page: 1 2 3 4 5 6 7 ... 19

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs35116017	chr13:88950640-88950641	Inactive region	lncRNA	n/a	Overlapped CNVs	n/a
2	rs539222753	chr13:88950660-88950661	Inactive region	lncRNA	n/a	Overlapped CNVs	n/a
3	rs147822523	chr13:88950666-88950667	Inactive region	lncRNA	n/a	Overlapped CNVs	n/a
4	rs34285730	chr13:88950712-88950713	Inactive region	lncRNA	n/a	Overlapped CNVs	n/a
5	rs547050700	chr13:88955404-88955405	Enhancers	n/a	n/a	Overlapped CNVs	n/a
6	rs565443060	chr13:88955419-88955420	Enhancers	n/a	n/a	Overlapped CNVs	n/a
7	rs532937013	chr13:88955491-88955492	Enhancers	n/a	n/a	Overlapped CNVs	n/a
8	rs551318701	chr13:88955494-88955495	Enhancers	n/a	n/a	Overlapped CNVs	n/a
9	rs558230273	chr13:88955511-88955512	Enhancers	n/a	n/a	Overlapped CNVs	n/a
10	rs373638905	chr13:88955531-88955532	Enhancers	n/a	n/a	Overlapped CNVs	n/a
11	rs376679186	chr13:88955533-88955534	Enhancers	n/a	n/a	Overlapped CNVs	n/a
12	rs536990058	chr13:88955610-88955611	Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
13	rs556509345	chr13:88955639-88955640	Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
14	rs112062001	chr13:88955660-88955661	Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
15	rs184231777	chr13:88955679-88955680	Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
16	rs554279166	chr13:88955688-88955689	Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
17	rs141580764	chr13:88955699-88955700	Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
18	rs187807279	chr13:88955719-88955720	Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
19	rs150506357	chr13:88955726-88955727	Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
20	rs79663816	chr13:88955744-88955745	Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
21	rs576672484	chr13:88955749-88955750	Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
22	rs569353307	chr13:88955756-88955757	Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
23	rs543803869	chr13:88955780-88955781	Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
24	rs562055471	chr13:88955805-88955806	Flanking Active TSS Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
25	rs528815240	chr13:88955830-88955831	Flanking Active TSS Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
26	rs540649791	chr13:88955837-88955838	Flanking Active TSS Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
27	rs543990768	chr13:88955845-88955846	Flanking Active TSS Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
28	rs371610101	chr13:88955849-88955850	Flanking Active TSS Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
29	rs558992209	chr13:88955862-88955863	Flanking Active TSS Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
30	rs532889575	chr13:88955884-88955885	Flanking Active TSS Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
31	rs192293584	chr13:88955903-88955904	Flanking Active TSS Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
32	rs569789107	chr13:88955904-88955905	Flanking Active TSS Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
33	rs139486234	chr13:88955926-88955927	Flanking Active TSS Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
34	rs548959379	chr13:88955952-88955953	Flanking Active TSS Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
35	rs184391582	chr13:88955953-88955954	Flanking Active TSS Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
36	rs188751917	chr13:88955988-88955989	Flanking Active TSS Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
37	rs529982354	chr13:88955996-88955997	Flanking Active TSS Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
38	rs566156910	chr13:88956017-88956018	Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
39	rs539595203	chr13:88956026-88956027	Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
40	rs61960901	chr13:88956029-88956030	Flanking Active TSS Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
41	rs576521520	chr13:88956049-88956050	Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
42	rs570758627	chr13:88956074-88956075	Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
43	rs555614828	chr13:88956079-88956080	Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
44	rs192817641	chr13:88956098-88956099	Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
45	rs548209028	chr13:88956128-88956129	Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
46	rs74562945	chr13:88956158-88956159	Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
47	rs533035286	chr13:88956160-88956161	Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
48	rs544735769	chr13:88956171-88956172	Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
49	rs532410985	chr13:88956173-88956174	Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
50	rs149686429	chr13:88956226-88956227	Enhancers	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:86)

Disease	PMID	Source
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	21080181	CNVD
HIV/AIDS	22032296	CNVD
Prostate cancer	16705090	CNVD
High-proliferative meningiomas	17937814	CNVD
Cancer	20164919	CNVD
Autism	22495311	CNVD
Chordoma	21602918	CNVD
Bladder cancer	21949216	CNVD
Acute myeloid leukemia	16864856	CNVD
Burkitt''s lymphoma	18698080	CNVD
Cancer	21637783	CNVD
Medulloblastoma	21979893	CNVD
Chronic lymphocytic leukemia	21518781	CNVD
colon cancer	17210682	CNVD
Endometrial cancer	22040021	CNVD
Colorectal cancer	20709793	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	21264507	CNVD
Glioblastoma multiforme	19960244	CNVD
Glioblastoma multiforme	17387387	CNVD
Hepatocellular carcinoma	22174799	CNVD
Ovarian cancer	20844748	CNVD
Colorectal cancer	19359472	CNVD
Intracranial aneurysm	19064780	CNVD
Breast cancer	19287154	CNVD
Acute myeloid leukemia	18379011	CNVD
Human rectal carcinomas	16397240	CNVD
Olfactory neuroblastoma	18408657	CNVD
Multiple myeloma	17077331	CNVD
Ependymoma	16718352	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Colorectal cancer	16272173	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Gastrointestinal stromal cancer	16982739	CNVD
Breast cancer	16608533	CNVD
Neuroblastoma	18923191	CNVD
Ovarian cancer	22174824	CNVD
Myoepithelioma	18604193	CNVD
Breast cancer	17133270	CNVD
Prostate cancer	18632612	CNVD
Small bowel adenocarcinoma	21586687	CNVD
Developmental delay	21147756	CNVD
Melanoma	18172304	CNVD
Prostate cancer	16573809	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Basal cell lymphoma	17053054	CNVD
Non-syndromic sensorineural hearing loss	18496225	CNVD
Metanephric adenoma	20802469	CNVD
High-grade prostatic intraepithelial neoplasia	16573809	CNVD
Gastric cancer	17908304	CNVD
Splenic marginal zone lymphoma	18492102	CNVD
Liposarcoma	21253554	CNVD
Acute promyelocytic leukemia	19109227	CNVD
Chronic lymphocytic leukemia	20421269	CNVD
Acute lymphoblastic leukemia	21980252	CNVD
Acute myeloid leukemia	20729466	CNVD
abnormal development	18461090	CNVD
small cell lung cancer	20016488	CNVD
Lung cancer	18438408	CNVD
Non-syndromic sensorineural hearing loss	20606397	CNVD
Congenital anomalies of the kidney and urinary tract	18316590	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Esophageal cancer	21851588	CNVD
Prostate cancer	21965145	CNVD
Gastrointestinal stromal cancer	20818650	CNVD
Cancer	21220470	CNVD
Cancer	21183584	CNVD
Omodysplasia	19481194	CNVD
Breast cancer	22032731	CNVD
Mantle cell lymphoma	19690137	CNVD
Rhabdomyosarcoma	17210683	CNVD
Ovarian clear cell carcinoma	21343371	CNVD
Breast cancer	21364760	CNVD
Mental retardation	17847001	CNVD
Medulloblastoma	19270706	CNVD
Non-small cell lung cancer	16651412	CNVD
Myelofibrosis	22110671	CNVD
coloboma	21285886	CNVD
Non-syndromic sensorineural hearing loss	22037309	CNVD
Osteosarcoma	21215367	CNVD

Chromatin state (count:34 , 50 per page) page: 1

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr13:88955400-88955600	Enhancers	Primary B cells from peripheral blood	blood
2	chr13:88955600-88955800	Enhancers	Primary B cells from cord blood	blood
3	chr13:88955600-88956000	Active TSS	Primary B cells from peripheral blood	blood
4	chr13:88955600-88956200	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Male	--
5	chr13:88955800-88956200	Flanking Active TSS	Primary B cells from cord blood	blood
6	chr13:88956000-88957000	Enhancers	Primary B cells from peripheral blood	blood
7	chr13:88956200-88956600	Enhancers	Primary B cells from cord blood	blood
8	chr13:88970400-88970600	Enhancers	Pancreas	Pancrea
9	chr13:88972200-88973000	Enhancers	H9 Derived Neuron Cultured Cells	ES cell derived
10	chr13:88997000-89002000	Weak transcription	ES-UCSF4 Cell Line	embryonic stem cell
11	chr13:88998000-88998200	Enhancers	H1 Derived Mesenchymal Stem Cells	ES cell derived
12	chr13:89002200-89002600	Enhancers	Fetal Heart	heart
13	chr13:89008000-89008200	Enhancers	Gastric	stomach
14	chr13:89013000-89013200	Enhancers	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
15	chr13:89013000-89013400	Enhancers	Fetal Heart	heart
16	chr13:89021200-89021800	Enhancers	Fetal Lung	lung
17	chr13:89025800-89026000	ZNF genes & repeats	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
18	chr13:89028000-89036200	Weak transcription	ES-UCSF4 Cell Line	embryonic stem cell
19	chr13:89029200-89029800	Active TSS	Primary Natural Killer cells fromperipheralblood	blood
20	chr13:89035800-89037400	Enhancers	HUES48 Cell Line	embryonic stem cell
21	chr13:89036200-89038200	Enhancers	iPS-18 Cell Line	embryonic stem cell
22	chr13:89036400-89036800	Enhancers	iPS-20b Cell Line	embryonic stem cell
23	chr13:89036600-89037000	Enhancers	HUES64 Cell Line	embryonic stem cell
24	chr13:89036600-89037600	Enhancers	HUES6 Cell Line	embryonic stem cell
25	chr13:89036800-89037000	Flanking Active TSS	iPS-20b Cell Line	embryonic stem cell
26	chr13:89036800-89037800	Enhancers	iPS-15b Cell Line	embryonic stem cell
27	chr13:89037000-89037200	Active TSS	iPS-20b Cell Line	embryonic stem cell
28	chr13:89037200-89037400	Flanking Active TSS	iPS-20b Cell Line	embryonic stem cell
29	chr13:89068800-89069600	Enhancers	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
30	chr13:89068800-89069600	Enhancers	HUES64 Cell Line	embryonic stem cell
31	chr13:89069000-89069600	Enhancers	HUES6 Cell Line	embryonic stem cell
32	chr13:89069000-89069600	Enhancers	iPS-18 Cell Line	embryonic stem cell
33	chr13:89069200-89069600	Enhancers	HUES48 Cell Line	embryonic stem cell
34	chr13:89075400-89075600	Bivalent Enhancer	Gastric	stomach

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links